The Trade Desk (TTD) stock fell 7% after Omnicom ordered an independent pricing audit, following Publicis’s break with the platform over alleged fees.

Salesforce (CRM) stock tumbles 6% after missing revenue estimates for the first time since 2006. Weak guidance and AI concerns weigh on the software sector.

Coinbase (COIN) dropped 8% and Circle fell 18% after CLARITY Act draft proposed banning stablecoin yield. Citi holds Buy rating with $400 target.

ASML stock trades 10% below highs after SK Hynix’s $8B order. 31 analysts rate it Moderate Buy with $1,475 target. Is now the time to invest?

Abbott (ABT) finalized its $21B acquisition of Exact Sciences (EXAS) on March 23, 2026, paying $105 per share in cash. EXAS is now delisted from Nasdaq.

Fundrise Innovation Fund (VCX) soars 740% since NYSE debut, trading 1,300% above NAV. Anthropic is the fund’s top holding at 21% of the portfolio.

Grab (GRAB) stock gained 4.81% following the announcement of $400M in share buybacks via JPMorgan and Morgan Stanley, funded entirely from cash.

Nvidia CEO Jensen Huang claims AGI has arrived, but his definition differs from traditional views. NVDA stock dips 0.3% as he projects $3T revenue.

Dollarama (DOL) stock fell 7.56% despite Q4 profit reaching $392.5M, revenue of $2.1B, and a 13% dividend increase. Why did investors sell off?

ImmunityBio (IBRX) shares dropped 21% after FDA issued warning letter citing false promotional claims about bladder cancer drug ANKTIVA in ads and podcast.